Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jfo.2019.10.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Iodine-125 plaque brachytherapy for the treatment of iris cavernous hemangioma.
Can J Ophthalmol
October 2024
Ocular Oncology Service, Princess Margaret Cancer Center/University Health Network, University of Toronto, Toronto, ON, Canada. Electronic address:
Phenotypic and cytogenetic variability of patau syndrome in Morocco.
Afr Health Sci
December 2023
Department of Genetics, Clinical Research Center, Mohammed VI University Hospital Center of Marrakech, Morocco.
Article Synopsis
- The study aimed to analyze the phenotypic and cytogenetic characteristics of trisomy 13 in a Moroccan population involving 9 diagnosed cases.
- A slight female predominance was observed, with major clinical findings including severe physical and developmental abnormalities such as holoprosencephaly, cleft lip and palate, and congenital heart defects.
- The cytogenetic analysis revealed that most cases had free and homogeneous trisomy 13, which often resulted in early mortality, while one variant, partial trisomy 13 (t(13;18)), had better outcomes with patients surviving longer but still facing significant health issues.
Indocyanine green-enhanced transpupillary thermotherapy for juxtapapillary retinal capillary hemangioblastoma.
Indian J Ophthalmol
August 2024
The Operation Eyesight Universal Institute for Eye Cancer, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.
Purpose: To study the clinical presentation and treatment outcomes of indocyanine green-enhanced transpupillary thermotherapy (ICG-TTT) for treatment-naïve juxtapapillary retinal capillary hemangioblastoma (JRCH).
Methods: A prospective interventional case series. The technique involved ICG dye infusion 45 seconds prior to application of TTT.
Narrow Angle Associated With an Iris Cavernous Hemangioma.
JAMA Ophthalmol
August 2023
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata.
Eur J Dermatol
September 2022
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, China
Background: The ocular features of phacomatosis pigmentovascularis (PPV) have rarely been reported, and glaucoma is the leading cause of blindness in patients with this condition. To protect vision in these patients, it is important to identify glaucoma as early as possible.
Objectives: To systematically report the systemic and ocular manifestations of phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata, and to investigate a glaucoma risk scoring system.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!